Zusammenfassung
Aufgrund der prokoagulatorischen Eigenschaften des Trophoblasten bzw. der Plazenta und der vermehrten Produktion von Gerinnungsfaktoren überwiegen zum Ende des dritten Trimenons prokoagulatorische Effekte bei gleichzeitig geminderter Fibrinolyse. Umgekehrt kann das Fibrinogen in Verbindung mit einer Messung des Blutverlustes im Falle einer schweren peripartalen Blutung (PPH; >500 ml bzw. 1000 ml Blutverlust) hinweisgebend für den Schweregrad der Blutung sein. In der Therapie der PPH sollten hämostaseologische, operative und ggf. interventionelle radiologische Therapieansätze ineinandergreifen. Sie umfassen u. a. die zügige Steigerung der Uteruskontraktion in Verbindung mit einer operativen Kompression, die frühzeitige Gabe von Tranexamsäure zur Vermeidung der Hyperfibrinolyse und die Wiederherstellung eines ausreichenden Gerinnungspotenzials. Alle Therapieschritte sollten in einem interdisziplinär abgestimmten Algorithmus auf Basis der aktuellen AWMF-Leitlinie trainiert werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Abbassi-Ghanavati M, Greer LG, Cunningham FG (2009) Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 114(6):1326–31
Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, Hunt LP, Draycott T (2010) Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG 117(8):929–36
Bateman BT, Berman MF, Riley LE, Leffert LR (2010) The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 110 (5):1368–73
Bose P, Regan F, Paterson-Brown S (2006) Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 113(8):919–24
Brenner B (2004) Haemostatic changes in pregnancy. Thromb Res 114(5–6):409–14
Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H et al. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5: 266–73
Collins PW, Lilley G, Bruynseels D (2014) Fibrin-based clot formation an early and rapidly biomarker for progression of postpartum hemorrhage: a prospective study. Blood 124: 585–95
Collins P, Abdul-Kadir R, Thachil J, for the Subcommittees on Women’s Health Issues in Thrombosis and Haemostasis and on Disseminated Intravascular Coagulation (2016) Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. J Thromb Haemost 14: 205–10
Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH et al. (2012) Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 108: 984–9
de Lloyd L, Bovington R, Kaye A, Collis RE, Rayment R, Sanders J et al. (2011) Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 20: 135–41
Descargues G, Pitette P, Gravier A, Roman H, Lemoine JP, Marpeau L (2001) Missed diagnosis of postpartum hemorrhage. J Gynecol Obstet Biol Reprod (Paris) 30(6):590–600
Driessen M, Bouvier-Colle MH, Dupont C, Khoshnood B, Rudigoz RC, Deneux-TharauxC Pithagore 6 Group (2011) Postpartum hemorrhage resulting from uterine atony after vaginal delivery. Obstet Gynecol 117(1):21–31
Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, Mandelbrot L, Tillouche N, Fontaine S, Le Goueff F, Depret-Mosser S, Vallet B EXADELI Study Group, Susen S (2011) High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 15(2):R117
Gai MY, Wu LF, Su QF, Tatsumoto K (2004) Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 112(2):154–7
Gayat E, Resche-Rigon M, Morel O, Rossignol M, Mantz J, Nicolas-Robin A et al. (2011) Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med 37: 1816–25
Girard et al. (2013) Schweiz Med Forum 13(50):1033–1038. http://www.sgar-ssar.ch/fileadmin/user_upload/user_saoa/PPH_Alg2g.pdf
Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C (2011) Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol 28(3):233–40
Haeri S, Dildy GA 3rd (2012) Maternal mortality from hemorrhage. Semin Perinatol 36(1):48–55
Hansen AT, Andreasen BH, Salving JD, Hvas AM (2011) Changes in fibrin D-dimer, fibrinogen, and protein S during pregnancy. Scand J Clin Lab Invest 71(2):173–6
Hui C, Lili M, Libin C, Rui Z, Fang G, Ling G, Jianping Z (2012) Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases. Arch Gynecol Obstet 285(5):1231–6
Kaufner L, Weizsacker K, Spies C, Feldheiser A, von Heymann C (2012) Emergency caesarean section and interdisciplinary emergency concepts for the delivery room – »What to do if it is urgent?« Anasthesiol Intensivmed Notfallmed Schmerzther 47(1):14–21
Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, Joseph KS, Lewis G, Liston RM, Roberts CL, Oats J, Walker J (2009) Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 9:55–65
Leitlinie »Peripartale Blutungen, Diagnostik und Therapie«. AWMF-Register Nr. 015/063 vom 01. April 2016
Levy JH, Welsby I, Goodnough LT (2014) Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 54(5):1389–405
Lockwood CJ (2006) Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 49(4):836–43
Mellin-Olsen J, Staender S, Whitaker DK, Smith AF (2010) The Helsinki Declaration on Patient Safety in Anaesthesiology. Eur J Anaesthesiol 27(7):592–7
Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z (2014) Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 13 2:CD003249
Novikova N, Hofmeyr GJ, Cluver C (2015) Tranexamic acid for preventing postpartum hemorrhage. Cochrane Database Syst Rev 6:CD007872
Othman M, Falcón BJ, Kadir R (2010) Global hemostasis in pregnancy: are we using thromboelastography to its full potential. Semin Thromb Hemost 36(7):738–46
Schlembach D, Mörtl MG (2010) Postpartale Hämorrhagie – Von der Definition über die Klinik zur Diagnose. Speculum 28(1):5–9
Schlembach D, Mörtl MG, Girard T, Arzt W, Beinder E, Brezinka C, Chalubinski K, Fries D, Gogarten W, Hackelöer BJ, Helmer H, Henrich W, Hösli I, Husslein P, Kainer F, Lang U, Pfanner G, Rath W, Schleussner E, Steiner H, Surbek D, Zimmermann R (2014) Management of postpartum hemorrhage (PPH): Algorithm of the interdisciplinary D-A-CH consensus group PPH (Germany – Austria – Switzerland). Anaesthesist 63(3):234–42
Sentilhes L, Vayssière C, Deneux-Tharaux C, Aya AG, Bayoumeu F, Bonnet MP, Djoudi R, Dolley P, Dreyfus M, Ducroux-Schouwey C, Dupont C, François A, Gallot D, Haumonté JB, Huissoud C, Kayem G, Keita H, Langer B, Mignon A, Morel O, Parant O, Pelage JP, Phan E, Rossignol M, Tessier V, Mercier FJ, Goffinet F (2016) Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol 198:12–21
Senturk MB, Cakmak Y, Yildiz G, Yildiz P (2013) Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial. Arch Gynecol Obstet 287(4):641–5
Solomon C, Collis RE, Collins PW (2012) Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 109(6):851–63
Swanepoel AC, Pretorius E (2014) Erythrocyte-platelet interaction in uncomplicated pregnancy. Microsc Microanal 20: 1848–1860
Thachil J, Toh CH (2009) Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Reviews 23: 167–176
Tunçalp O, Souza JP, Gülmezoglu M (2013) New WHO recommendations on prevention and treatment of postpartum hemorrhage. Int J Gynaecol Obstet 123(3):254–6
Westhoff G, Cotter AM, Tolosa JE (2013) Prophylactic oxytocin for the third stage of labour to prevent postpartum hemorrhage. Cochrane Database Syst Rev 10:CD001808
Wikkelsø AJ, Edwards HM, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, Ekelund K, Hanke G, Secher EL, Sharif HF, Pedersen LM, Troelstrup A, Lauenborg J, Mitchell AU, Fuhrmann L, Svare J, Madsen MG, Bødker B, Møller AM FIB-PPH trial group (2015) Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth 114(4):623–33
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Kaufner, L., v. Heymann, C. (2017). Gerinnung in der Schwangerschaft und peripartale Blutung. In: Kranke, P. (eds) Die geburtshilfliche Anästhesie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54375-7_22
Download citation
DOI: https://doi.org/10.1007/978-3-662-54375-7_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54374-0
Online ISBN: 978-3-662-54375-7
eBook Packages: Medicine (German Language)